Showing results (141-150 of 2,345) with videos related to
Sort By:
Pageof 235
The AAPS Journal|August 3, 2016
Regulatory Experience with In Vivo In Vitro Correlations (IVIVC) in New Drug ApplicationsSandra Suarez-Sharp, Min Li, John Duan, et al.The AAPS Journal|August 7, 2016
Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass SpectrometryMichael G Feasel, Ariane Wohlfarth, John M Nilles, et al.The AAPS Journal|September 4, 2025
Recent Advances in Bioanalytical Methods for Quantification and Pharmacokinetic Analyses of Antibody-Drug ConjugatesR M Naseer Khan, Yi Zeng, Abdul-Azeez A Lanihun, et al.The AAPS Journal|July 25, 2016
Physiologically Based Absorption Modeling to Explore the Impact of Food and Gastric pH Changes on the Pharmacokinetics of AlectinibNeil J Parrott, Li J Yu, Ryusuke Takano, et al.The AAPS Journal|May 13, 2020
Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung AbsorptionJohanna Eriksson, Erik Sjögren, Hans Lennernäs, et al.The AAPS Journal|May 28, 2020
Physiologically Based Absorption Modelling to Explore the Impact of Food and Gastric pH Changes on the Pharmacokinetics of EntrectinibNeil Parrott, Cordula Stillhart, Marc Lindenberg, et al.The AAPS Journal|May 29, 2020
High-Dose IV Administration of Rasburicase Suppresses Anti-rasburicase Antibodies, Depletes Rasburicase-Specific Lymphocytes, and Upregulates Treg CellsHui Xu, Gerald M Feldman, Edward E MaxThe AAPS Journal|August 24, 2022
Determination of the Number of Tissue Groups of Kinetically Distinct Transit Time in Whole-Body Physiologically Based Pharmacokinetic (PBPK) Models I: Theoretical Consideration of Bottom-Up Approach of Lumping Tissues in Whole-Body PBPKYoo-Seong Jeong, Min-Soo Kim, Suk-Jae ChungThe AAPS Journal|May 19, 2021
Developing Tools to Evaluate Non-linear Mixed Effect Models: 20 Years on the npde AdventureEmmanuelle Comets, France MentréThe AAPS Journal|May 1, 2021
FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meeting report, summary of challenges/gaps, and future perspectiveJane P F Bai, Brian J Schmidt, Kapil G Gadkar, et al.Pageof 235